(Q36499342)

14 August 2017

1 reference

title

Magnesium therapy within 48 hours of an aneurysmal subarachnoid hemorrhage: neuro-panacea (English)

1 reference

aneurysmal subarachnoid hemorrhage

14 August 2017

1 reference

5

Tony Gin

1 reference

14 August 2017

1

George K C Wong

1 reference

14 August 2017

3

Wai S Poon

1 reference

14 August 2017

2

Matthew T V Chan

1 reference

14 August 2017

Ronald Boet

4

1 reference

14 August 2017

1 June 2006

1 reference

14 August 2017

Neurological Research

1 reference

14 August 2017

28

1 reference

14 August 2017

4

1 reference

14 August 2017

431-435

1 reference

One-year death rate in 270 patients with suspected acute myocardial infarction, initially treated with intravenous magnesium or placebo

14 August 2017

1 reference

https://api.crossref.org/works/10.1179%2F016164106X115035

Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X115035

Intravenous magnesium for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X115035

Hormone-stimulated Mg(2+) accumulation into rat hepatocytes: a pathway for rapid Mg(2+) and Ca(2+) redistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X115035

Hypomagnesemia after aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X115035

A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X115035

Delayed treatment with magnesium: reduction of brain infarction and improvement of electrophysiological recovery following transient focal cerebral ischemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X115035

Dose finding study of intravenous magnesium sulphate in transient focal cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X115035

Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X115035

Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X115035

Intravenous magnesium sulfate administration in a patient with refractory vasospasm following subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X115035

Magnesium and experimental vasospasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X115035

Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X115035

Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X115035

Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X115035

Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X115035

Trial design in "magnesium sulphate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial".

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X115035

Cerebrospinal fluid magnesium level as a prognostic factor in ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X115035

Magnesium protection against in vitro cerebral vasospasm after subarachnoid haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X115035

Magnesium: a useful adjunct in the prevention of cerebral vasospasm following aneurysmal subarachnoid haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X115035

21 January 2018

Identifiers

DOI

10.1179/016164106X115035

1 reference

14 August 2017

1 reference

PubMed ID

16759446